Growth factors, cytokines, and enzyme inhibitors from placental tissues

The “growth factors, cytokines, and enzyme inhibitors from placental tissues” refer to a diverse set of proteins and small molecules naturally produced by placental cells, particularly mesenchymal stem/stromal cells (MSCs), that are involved in the regulation of the healing process and tissue regeneration. These factors function primarily through paracrine signaling—meaning they are secreted into the tissue environment, where they interact with and modulate the behavior of local cells to promote a coordinated healing response. Key classes include classic growth factors (e.g., vascular endothelial growth factor [VEGF], fibroblast growth factor [FGF], transforming growth factor-beta [TGF-β]), cytokines (e.g., interleukins such as IL-6, IL-8, TNF-α), enzyme inhibitors, and chemokines[1][2][3][4][6][7]. These molecules collectively contribute to immunomodulation, stimulation of cell proliferation and migration, reduction of fibrosis, support for neovascularization, and enhancement of tissue integration and wound closure. Their combined use as a therapeutic source is a strategy under research and development in regenerative medicine, rather than referencing a singular, canonical drug target or molecular entity[2][3][4][6][7]. Note: This entry is not a discrete molecule, protein, or receptor, but a description for a mixture of bioactive factors derived from placenta for therapeutic use. For structured databases, such a description would be marked as non-canonical and too broad; instead, each constituent (e.g., "Vascular endothelial growth factor," "Interleukin-6," etc.) should be tracked as a separate target for structured annotation[1][2][3].

Paracrine signaling (secretion of regulatory molecules); Modulation of immune response; Regulation of cell proliferation and differentiation; Induction of angiogenesis; Inhibition of fibrogenic pathways